RT Journal Article
SR Electronic
T1 581 Final analysis of 2-THE-TOP: a phase 2 study of TTFields (Optune) plus pembrolizumab plus maintenance temozolomide (TMZ) in patients with newly diagnosed glioblastoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A661
OP A661
DO 10.1136/jitc-2023-SITC2023.0581
VO 11
IS Suppl 1
A1 Tran, David
A1 Ghiaseddin, Ashley
A1 Chen, Dongjiang
A1 Le, Son
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A661.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.